SEC Filing Analysis: HEALTHEQUITY, INC. (HQY)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at HealthEquity has filed a notice of a proposed sale of 4,500 shares, valued at approximately $430,000, under a pre-established 10b5-1 trading plan.
• Market Impact: The transaction is of low materiality and is unlikely to have a meaningful impact on the stock price.

Company Information

Field	Value
Company	HEALTHEQUITY, INC.
Ticker Symbol	HQY
CIK	0001428336
Industry	Services-Business Services, NEC

Insider Information

Field	Value
Name	DELANO LADD
CIK	0001683056
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-12-19 (Approximate Sale Date)
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	4,500
Price Per Share	$95.50
Total Value	$429,750
Shares Owned After	Not Disclosed
Ownership Type	Not Disclosed

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$429,750
% of Market Cap	0.0049%
Shares Transacted	4,500
% of Shares Outstanding	0.0052%
Post-Transaction Ownership	Not Disclosed
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $8.77 billion, this $430k transaction is financially insignificant, representing a tiny fraction of the company's total value.
• Transaction Significance: The sale constitutes a negligible percentage of both the market cap and the total shares outstanding, categorizing it as a routine event with minimal market-moving potential.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is small in scale and conducted under a 10b5-1 plan adopted on June 12, 2025. Pre-planned sales are generally not considered indicative of an insider's current outlook on the company's future performance.

Volume & Sentiment

• Expected Volume Impact: Negligible. The number of shares is too small to affect trading volume in a meaningful way.
• Sentiment Indicator: Neutral. This is a routine, pre-planned sale by an officer, likely for personal financial management, and does not signal a change in insider sentiment.

Additional Context

Transaction Notes

• Special Circumstances: The filing indicates this is a proposed sale under a 10b5-1 trading plan. The filing also discloses two prior sales in the preceding three months, totaling 3,000 shares, reinforcing the pattern of pre-planned dispositions.